Unless you have Wilson's disease, or you know someone who does, you've probably never heard of this rare genetic condition.

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

A safety committee will review all evidence from trials and studies to shed more light on the potential risk of NAION.

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...